## Gene Summary
GSTT2, or Glutathione S-transferase theta 2, belongs to the GST family, which plays a critical role in cellular detoxification. These enzymes are involved in the catalysis of the conjugation of glutathione (GSH) to a variety of endogenous and exogenous electrophilic compounds. GSTT2 is primarily expressed in the liver and kidneys. The protein is involved in the metabolism of toxic compounds and reactive oxygen species, thereby protecting cells from oxidative damage and maintaining cellular redox balance. Notably, the enzyme metabolizes compounds like dichloromethane and ethylene oxide.

## Gene Drugs, Diseases, Phenotypes, and Pathways
GSTT2 is implicated in various metabolic pathways concerning the detoxification of electrophilic compounds. Deregulation or polymorphisms in this gene can influence the susceptibility to toxins and carcinogens, potentially leading to diseases such as some forms of cancer. The gene is associated with the glutathione metabolism pathway, which is crucial for cellular defense mechanisms against oxidative stress. Furthermore, phenotypically, variabilities in GSTT2 expression or function may be expressed as differences in individual responses to toxic environmental exposures.

## Pharmacogenetics
In pharmacogenetics, GSTT2 has been studied for its role in influencing the metabolism and effectiveness of certain drugs. Specifically, the gene's product is known for its involvement in drug metabolism pathways that can affect the pharmacokinetics and dynamics of drugs, notably those undergoing conjugation reactions with glutathione. Research into GSTT2 has revealed a potential link with variations in treatment outcomes in diseases such as cancer, where chemotherapy drugs might rely on glutathione pathways for detoxification and efficacy. This enzyme's polymorphisms could affect the toxicity and effectiveness of chemotherapeutic agents, although specific drugs directly influenced by GSTT2 variations are not as extensively documented compared to its family members like GSTM1 and GSTP1. Further studies are required to establish clearer pharmacogenetic associations.